Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03967743 · ClinicalTrials.gov registry record
Application of a Systematic Developmental Assessment to a Novel Population: Infants With Rare Genetic Disorders
A clinical trial of Genetic Disease and Genetic Predisposition to Disease, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT03967743: Recruiting study of Genetic Disease and Genetic Predisposition to Disease, sponsored by Boston Children's Hospital.
NCT03967743 is a study of Genetic Disease and Genetic Predisposition to Disease that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 150 participants, below the 2,556-participant average among 30 other Genetic Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03967743, a study of Genetic Disease and Genetic Predisposition to Disease, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of this study is to apply a well-established model of developmental surveillance (which evolved to characterize the outcomes of very low birth weight infants) to infants with genetic disorders. A novel clinical model for infants with rare genetic disorders has been created as a joint initiative between the Division of Newborn Medicine's NICU Growth and Developmental Support Programs (NICU GraDS) program and the Division of Genetics at Boston Children's Hospital (BCH). This study plans to enroll patients with genetic syndromes seen in this clinic into a prospective, longitudinal study in order to characterize their developmental profiles and needs.
Primary Outcome
Study subjects will be followed in the NICU GraDS program until approximately 3 years of age, though there will be prospective review of medical records until a maximum age of 18 years.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-08-26 |
| Est. Completion | 2025-12-01 |
What NCT03967743 shows while recruiting
NCT03967743 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 2,556-participant average among 30 other Genetic Disease trials with a reported enrollment target (94% lower).
The record links to 5 conditions, with Genetic Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03967743 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03967743 about?
NCT03967743 is a clinical study titled "Application of a Systematic Developmental Assessment to a Novel Population: Infants With Rare Genetic Disorders". The main objective of this study is to apply a well-established model of developmental surveillance (which evolved to characterize the outcomes of very low birth weight infants) to infants with genetic disorders. A novel clinical model for infants with rare genetic disorders has been created as a jo...
What is the current status of trial NCT03967743?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2019-08-26. Estimated completion is 2025-12-01.
What conditions does trial NCT03967743 study?
This clinical trial studies the following conditions: Genetic Disease, Genetic Predisposition to Disease, Development, Child, Development, Infant, Genetic Syndrome.
Who is sponsoring clinical trial NCT03967743?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03967743 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03967743's enrollment target sits among peer trials
150 17th of 30 higher than 13 of 30 other Genetic Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Genetic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome
RECRUITING
-
Rett Syndrome Registry
RECRUITING
-
Natural History Study of Patients with HPDL Mutations
RECRUITING
-
Diagnostic Odyssey: Whole Genome Sequencing (WGS)
RECRUITING
-
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI